Laserpor Ap Atrial Endocard Electr Ld
Telectronics
FDA Clearance Information
The Laserpor AP Atrial Endocardial Electrode was cleared through the FDA 510(k) pathway on February 12, 1982. Manufactured by Telectronics, it is classified as a Class III device under product code DTB.
What It Is
FDA-Cleared Indications
- Use as an atrial endocardial electrode for delivering electrical stimulation to the atrium.
- Use with compatible cardiac pacing systems when atrial endocardial stimulation is clinically indicated.
Clinical Applications
- Atrial pacing in patients who require electrical stimulation of the atrium.
- Placement of an endocardial electrode within the atrium during cardiac pacing procedures.
- Use with compatible cardiac pacing equipment under the direction of a qualified cardiac electrophysiology team.
Practical Considerations
- The record identifies this as a Class III device cleared under 510(k) K820121; current availability, labeling, and compatibility should be confirmed with the FDA and manufacturer records.
- The electrode must be compatible with the intended pacing system and connector configuration.
- Placement requires appropriate training in intracardiac lead or electrode positioning and confirmation of electrical performance.
- The record does not provide specific dimensions, sizes, MRI-conditional labeling, durability, or contraindications.
- MRI safety should not be assumed. The complete implanted system and current manufacturer labeling must be reviewed before MRI.
Frequently Asked Questions
What is the Laserpor AP Atrial Endocardial Electrode used for?
It is used to manage atrial arrhythmias by delivering electrical impulses to the heart's atrial endocardium.
What specialties typically use this device?
Cardiologists and electrophysiologists typically use this device in cardiac procedures.
What are the FDA-cleared indications?
The device is indicated for patients with atrial arrhythmias requiring electrical stimulation, such as atrial fibrillation or flutter.